EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Arrhythmias in Autoimmune Diseases: Immune-Mediated Mechanisms and Management

Kamala P Tamirisa, Jorge A Irizarry-Caro iD, Ian Curnutt iD, Devika Adusumilli iD, Mia Jose, Meenakshi Jolly iD, Estelle Torbey, Annabelle S Volgman iD

Journal of Cardiovascular Development and Disease · 22.07.2026 · 13 (7) · 343

DOI: 10.3390/jcdd13070343 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 22.07.2026. Verfasst von Kamala P Tamirisa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, UT Southwestern Medical Center, Dallas, TX 75390, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases substantially increase the risk of atrial and ventricular arrhythmias and sudden cardiac death through shared immune-mediated mechanisms. Pro-inflammatory cytokines, autoantibodies, and progressive myocardial fibrosis disrupt ion channel function, impair conduction, and create re-entrant substrates. Across systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc), these pathways manifest as atrial fibrillation, ventricular arrhythmias, conduction disease, and heightened arrhythmic mortality. Anti Ro/SSA antibodies, in particular, contribute to QT prolongation and atrioventricular (AV) block, while cytokines such as TNF α, IL 1β, and IL 6 remodel electrophysiological properties and promote fibrosis. Advanced cardiac imaging, especially cardiac magnetic resonance (CMR), detects inflammation and fibrosis even when ejection fraction is preserved, enabling earlier intervention. Management requires a dual approach: standard arrhythmia therapies alongside aggressive control of systemic inflammation with disease-specific immunosuppression. Despite growing evidence, major gaps remain, including the absence of randomized trials targeting immune-driven arrhythmias and the need for integrated risk models incorporating inflammatory biomarkers.

Schlagwörter

Stichwörter der Autor:innen

arrhythmias in SLErheumatoid arthritis and atrial fibrillationsystemic sclerosis and arrhythmias

Autor:innen und Institutionen

  • Division of Cardiology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Division of Cardiology, UT San Antonio, San Antonio, TX 77030, USA.
  • Department of Internal Medicine, Kansas City University College of Osteopathic Medicine, Joplin, MO 64804, USA.
  • Medical City Fort Worth, Fort Worth, TX 76104, USA.
  • Senior High School, Carroll ISD, Southlake, TX 76092, USA.
  • Division of Rheumatology, Rush University Medical Center, Chicago, IL 60612, USA.

ORCID-Profile: Jorge A Irizarry-Caro, Ian Curnutt, Devika Adusumilli, Meenakshi Jolly, Annabelle S Volgman

Zitieren

APA

Tamirisa, K. P., Irizarry-Caro, J. A., Curnutt, I., Adusumilli, D., Jose, M., Jolly, M., Torbey, E., & Volgman, A. S. (2026). Arrhythmias in Autoimmune Diseases: Immune-Mediated Mechanisms and Management. Journal of Cardiovascular Development and Disease, 13(7), 343. https://doi.org/10.3390/jcdd13070343

Vancouver

Tamirisa KP, Irizarry-Caro JA, Curnutt I, Adusumilli D, Jose M, Jolly M, et al. Arrhythmias in Autoimmune Diseases: Immune-Mediated Mechanisms and Management. Journal of Cardiovascular Development and Disease. 2026;13(7):343. doi:10.3390/jcdd13070343

BibTeX
@article{Tamirisa2026,
  author = {Tamirisa, Kamala P and Irizarry-Caro, Jorge A and Curnutt, Ian and Adusumilli, Devika and Jose, Mia and Jolly, Meenakshi and Torbey, Estelle and Volgman, Annabelle S},
  title = {Arrhythmias in Autoimmune Diseases: Immune-Mediated Mechanisms and Management},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {7},
  pages = {343},
  doi = {10.3390/jcdd13070343}
}
Kostenlos starten →